Risedronate-functionalized manganese-hydroxyapatite amorphous particles: A potent adjuvant for subunit vaccines and cancer immunotherapy

Rational design of a cross-type HPV vaccine through immunodominance shift guided by a cross-neutralizing antibody

SurfPro-NN: A 3D point cloud neural network for the scoring of protein-protein docking models based on surfaces features and protein language models

Redeveloping antigen detection kits for the diagnosis of rat hepatitis E virus

Non-overlapping epitopes on the gHgL-gp42 complex for the rational design of a triple-antibody cocktail against EBV infection

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors

Structural basis for broad neutralization of human antibody against Omicron sublineages and evasion by XBB variant

Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies

Two antibodies show broad, synergistic neutralization against SARS-CoV-2 variants by inducing conformational change within the RBD

Risedronate-Functionalized Manganese-Calcium Phosphate Nanoparticles: A Potent Adjuvant for Subunit Vaccines and Cancer Immunotherapy

Structure and proposed DNA delivery mechanism of a marine roseophage

Critical Residues Involved in the Coassembly of L1 and L2 Capsid Proteins of Human Papillomavirus 16

Truncated glycoprotein E of varicella-zoster virus is an ideal immunogen for <i>Escherichia coli</i>-based vaccine design

Omics-guided bacterial engineering of Escherichia coli ER2566 for recombinant protein expression

Characterization of an Escherichia coli-derived triple-type chimeric vaccine against human papillomavirus types 39, 68 and 70

A bacterially expressed triple-type chimeric vaccine against human papillomavirus types 51, 69, and 26

Potential of conserved antigenic sites in development of universal SARS-like coronavirus vaccines

Structural basis for the synergistic neutralization of coxsackievirus B1 by a triple-antibody cocktail

Identification of a cross-neutralizing antibody that targets the receptor binding site of H1N1 and H5N1 influenza viruses

Endodomain truncation of the HIV-1 envelope protein improves the packaging efficiency of pseudoviruses

The neutralizing breadth of antibodies targeting diverse conserved epitopes between SARS-CoV and SARS-CoV-2

Three SARS-CoV-2 antibodies provide broad and synergistic neutralization against variants of concern, including Omicron

A Bacterially Expressed SARS-CoV-2 Receptor Binding Domain Fused With Cross-Reacting Material 197 A-Domain Elicits High Level of Neutralizing Antibodies in Mice

Structures of pseudorabies virus capsids

Cross-species tropism and antigenic landscapes of SARS-CoV-2 variants

A stepwise docking molecular dynamics approach for simulating antibody recognition with substantial conformational changes

Engineering for an HPV 9-valent vaccine candidate using genomic constitutive over-expression and low lipopolysaccharide levels in Escherichia coli cells

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Structural Basis for the Shared Neutralization Mechanism of Three Classes of Human Papillomavirus Type 58 Antibodies with Disparate Modes of Binding

Cryo-EM structures reveal the molecular basis of receptor-initiated coxsackievirus uncoating

Virus-Free and Live-Cell Visualizing SARS-CoV-2 Cell Entry for Studies of Neutralizing Antibodies and Compound Inhibitors

Near-atomic cryo-electron microscopy structures of varicella-zoster virus capsids

Genome re-sequencing and reannotation of the Escherichia coli ER2566 strain and transcriptome sequencing under overexpression conditions

Rational design of a multi-valent human papillomavirus vaccine by capsomere-hybrid co-assembly of virus-like particles

Recent Progress on the Versatility of Virus-Like Particles

Identification of Antibodies with Non-overlapping Neutralization Sites that Target Coxsackievirus A16

SARS-CoV-2 spike produced in insect cells elicits high neutralization titres in non-human primates

Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells

Viral neutralization by antibody-imposed physical disruption

HIV-1 Membrane-Proximal External Region Fused to Diphtheria Toxin Domain-A Elicits 4E10-Like Antibodies in Mice

Disrupting LILRB4/APOE Interaction by an Efficacious Humanized Antibody Reverses T-cell Suppression and Blocks AML Development

Ferritin nanocage-based antigen delivery nanoplatforms: Epitope engineering for peptide vaccine design

Construction of a bacterial surface display system based on outer membrane protein F

Hepatitis E vaccine candidate harboring a non-particulate immunogen of E2 fused with CRM197 fragment A

Characterization of native-like HIV-1 gp140 glycoprotein expressed in insect cells

Neutralization sites of human papillomavirus-6 relate to virus attachment and entry phase in viral infection

Atomic structures of enterovirus D68 in complex with two monoclonal antibodies define distinct mechanisms of viral neutralization

An IgM antibody targeting the receptor binding site of influenza B blocks viral infection with great breadth and potency

Rational design of a triple-type human papillomavirus vaccine by compromising viral-type specificity

N-terminal truncations on L1 proteins of human papillomaviruses promote their soluble expression in Escherichia coli and self-assembly in vitro

Discovery and structural characterization of a therapeutic antibody against coxsackievirus A10

Identification of Strategic Residues at the Interface of Antigen-Antibody Interactions by In Silico Mutagenesis

Characterization of capsid protein (p495) of hepatitis E virus expressed ID in Escherichia coli and assembling into particles in vitro

A multimechanistic antibody targeting the receptor binding site potently cross-protects against influenza B viruses

Atomic structures of Coxsackievirus A6 and its complex with a neutralizing antibody

A novel combined vaccine based on monochimeric VLP co-displaying multiple conserved epitopes against enterovirus 71 and varicella-zoster virus

Stop codon mutagenesis for homogenous expression of human papillomavirus L1 protein in Escherichia coli

Using a Machine-Learning Approach to Predict Discontinuous Antibody-Specific B-Cell Epitopes

A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice

A shared N-terminal hydrophobic tail for the formation of nanoparticulates

The C-Terminal Arm of the Human Papillomavirus Major Capsid Protein Is Immunogenic and Involved in Virus-Host Interaction

In vitro affinity maturation and characterization of anti-P24 antibody for HIV diagnostic assay

Molecular insights into the inhibition of HIV-1 infection using a CD4 domain-1-specific monoclonal antibody

Identification of a Highly Conserved and Surface Exposed B-cell Epitope on the Nucleoprotein of Influenza A Virus

Bacteria expressed hepatitis E virus capsid proteins maintain virion-like epitopes

Protection against Lethal Enterovirus 71 Challenge in Mice by a Recombinant Vaccine Candidate Containing a Broadly Cross-Neutralizing Epitope within the VP2 EF Loop

Virus-like particle-based human vaccines: Quality assessment based on structural and functional properties

Influence of mutations in hepatitis B virus surface protein on viral antigenicity and phenotype in occult HBV strains from blood donors

Properties and Therapeutic Efficacy of Broadly Reactive Chimeric and Humanized H5-Specific Monoclonal Antibodies against H5N1 Influenza Viruses

Role of heat-shock protein 90 in hepatitis E virus capsid trafficking

Molecular and Phylogenetic Analyses Suggest an Additional Hepatitis B Virus Genotype